George H. Quallich

Person

Groton, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Process for forming amorphous atorvastatin
- Patent number 9,056,831
- Issue date Jun 16, 2015
- Pfizer Inc.
- Antone John deBettencourt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for forming amorphous atorvastatin
- Patent number 8,686,163
- Issue date Apr 1, 2014
- Pfizer Inc.
- Antone J deBettencourt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for forming amorphous atorvastatin
- Patent number 8,258,315
- Issue date Sep 4, 2012
- Pfizer Inc.
- Antone J deBettencourt, III
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutically acceptable salts of sertraline and pharmaceutical...
- Patent number 7,094,930
- Issue date Aug 22, 2006
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline anhydrous and monohydrate benzoate salts of (2′S,3S)-3-...
- Patent number 7,038,061
- Issue date May 2, 2006
- Pfizer Inc.
- George J. Quallich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Citric acid salt of a therapeutic compound and pharmaceutical compo...
- Patent number 6,825,193
- Issue date Nov 30, 2004
- Pfizer Inc.
- George J. Quallich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Succinic acid salts of 5,7,14-triazatetracyclo[10.3.1.02,11...
- Patent number 6,794,388
- Issue date Sep 21, 2004
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing sertraline from chiral tetralone
- Patent number 6,593,496
- Issue date Jul 15, 2003
- Pfizer Inc.
- George H. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the production of enantiomerically pure or optically en...
- Patent number 6,444,854
- Issue date Sep 3, 2002
- Chiral Technologies Europe
- Oliver Dapremont
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing cyclic thioamides
- Patent number 6,388,127
- Issue date May 14, 2002
- Pfizer Inc.
- George Joseph Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citr...
- Patent number 6,387,925
- Issue date May 14, 2002
- Pfizer Inc.
- George Joseph Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of synthesis of pyrrole amides
- Patent number 6,262,272
- Issue date Jul 17, 2001
- Pfizer Inc.
- John Anthony Ragan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citra...
- Patent number 6,255,320
- Issue date Jul 3, 2001
- Pfizer Inc.
- George Joseph Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apo B-secretion/MTP inhibitory amides
- Patent number 6,121,283
- Issue date Sep 19, 2000
- Pfizer Inc.
- George Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enantioselective oxazaborolidine catalysts
- Patent number 6,037,505
- Issue date Mar 14, 2000
- Pfizer Inc.
- George Joseph Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enantioselective oxazaborolidine catalysts
- Patent number 6,005,133
- Issue date Dec 21, 1999
- Pfizer Inc.
- George Joseph Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apo B-secretion/MTP inhibitor hydrochloride salt
- Patent number 5,968,950
- Issue date Oct 19, 1999
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide deriva...
- Patent number 5,919,795
- Issue date Jul 6, 1999
- Pfizer Inc.
- George Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing chiral tetralone
- Patent number 5,750,794
- Issue date May 12, 1998
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of preparing azatetralones
- Patent number 5,677,458
- Issue date Oct 14, 1997
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of 3-bromo-5-chloro-2-alkyl-pyridine derivatives
- Patent number 5,608,071
- Issue date Mar 4, 1997
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process and chiral intermediates for thiazole antidiabetics
- Patent number 5,576,442
- Issue date Nov 19, 1996
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enantioselective oxazaborolidine catalysts
- Patent number 5,552,548
- Issue date Sep 3, 1996
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy ch...
- Patent number 5,539,128
- Issue date Jul 23, 1996
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of intermediates in the synthesis of ch...
- Patent number 5,512,689
- Issue date Apr 30, 1996
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing ketone enantiomer
- Patent number 5,466,880
- Issue date Nov 14, 1995
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-bromo-5-chloro-pyridines used as intermediates in the synthesis o...
- Patent number 5,436,344
- Issue date Jul 25, 1995
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Certain 3,4-dihydro-2H-pyrano[2,3-b]pyridines
- Patent number 5,336,771
- Issue date Aug 9, 1994
- Pfizer Inc.
- Charles W. Murtiashaw
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing ketone enantiomer
- Patent number 5,196,607
- Issue date Mar 23, 1993
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for (3S,4R)-3-[1(R)-t-butyl-dimethylsilyloxy)-ethyl]-4-[1...
- Patent number 5,075,439
- Issue date Dec 24, 1991
- Pfizer Inc.
- Frank R. Busch
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20140155627
- Publication date Jun 5, 2014
- Pfizer Inc.
- Antone John deBettencourt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20120289576
- Publication date Nov 15, 2012
- Pfizer Inc.
- Antone J. deBettencourt, III
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20110237642
- Publication date Sep 29, 2011
- Pfizer Inc.
- Antone J. deBettencourt, III
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for Forming Amorphous Atorvastatin
- Publication number 20080269314
- Publication date Oct 30, 2008
- Antone John Debetten-Court
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salt Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5...
- Publication number 20080262074
- Publication date Oct 23, 2008
- Pfizer, Inc.
- George Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-...
- Publication number 20040235936
- Publication date Nov 25, 2004
- Pfizer Inc.
- George Quallich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutically acceptable salts of sertraline and pharmaceutical...
- Publication number 20040198818
- Publication date Oct 7, 2004
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Citric acid salt of a therapeutic compound and pharmaceutical compo...
- Publication number 20030181444
- Publication date Sep 25, 2003
- Pfizer Inc.
- George J. Quallich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Succinic acid salts of 5,7,14-triazatetracyclo[10.1.02.11.04,9] -he...
- Publication number 20030149044
- Publication date Aug 7, 2003
- Pfizer Inc.
- George J. Quallich
- C07 - ORGANIC CHEMISTRY

George H. Quallich

Person

Patents Grantslast 30 patents

Process for forming amorphous atorvastatin

Process for forming amorphous atorvastatin

Process for forming amorphous atorvastatin

Pharmaceutically acceptable salts of sertraline and pharmaceutical...

Crystalline anhydrous and monohydrate benzoate salts of (2′S,3S)-3-...

Citric acid salt of a therapeutic compound and pharmaceutical compo...

Succinic acid salts of 5,7,14-triazatetracyclo&#x0005B;10.3.1.02,11...

Process for preparing sertraline from chiral tetralone

Process for the production of enantiomerically pure or optically en...

Process for preparing cyclic thioamides

Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citr...

Method of synthesis of pyrrole amides

Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citra...

Apo B-secretion/MTP inhibitory amides

Enantioselective oxazaborolidine catalysts

Enantioselective oxazaborolidine catalysts

Apo B-secretion/MTP inhibitor hydrochloride salt

Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide deriva...

Process for preparing chiral tetralone

Method of preparing azatetralones

Synthesis of 3-bromo-5-chloro-2-alkyl-pyridine derivatives

Process and chiral intermediates for thiazole antidiabetics

Enantioselective oxazaborolidine catalysts

Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy ch...

Process for the preparation of intermediates in the synthesis of ch...

Process for preparing ketone enantiomer

3-bromo-5-chloro-pyridines used as intermediates in the synthesis o...

Certain 3,4-dihydro-2H-pyrano[2,3-b]pyridines

Process for preparing ketone enantiomer

Processes for (3S,4R)-3-[1(R)-t-butyl-dimethylsilyloxy)-ethyl]-4-[1...

Patents Applicationslast 30 patents

Process for Forming Amorphous Atorvastatin

Process for Forming Amorphous Atorvastatin

Process for Forming Amorphous Atorvastatin

Process for Forming Amorphous Atorvastatin

Salt Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5...

Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-...

Pharmaceutically acceptable salts of sertraline and pharmaceutical...

Citric acid salt of a therapeutic compound and pharmaceutical compo...

Succinic acid salts of 5,7,14-triazatetracyclo[10.1.02.11.04,9] -he...

Succinic acid salts of 5,7,14-triazatetracyclo[10.3.1.02,11...

Salt Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5...